Clinical trial
Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
NCT03634501
Study timeline
Study start (actual)2018-10-26Date precision: day
Registry last updated2019-01-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Breast Cancerunresolved
Colon Cancerunresolved
Pancreatic Cancerunresolved
Ovarian Cancerunresolved
Interventions
Activated NKBIOLOGICAL
Sponsors & collaborators
Xuanwu Hospital, Beijinglead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03634501 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.